Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI: study protocol (ISRCTN62866759)
After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-year survival of 21% achieved with adjuvant chemotherapy. Investigators from the Virginia Maso...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 April 2005
|
| In: |
BMC cancer
Year: 2005, Jahrgang: 5, Pages: 1-8 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-5-37 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-5-37
|
| Verfasserangaben: | H.P. Knaebel, A. Märten, J. Schmidt, K. Hoffmann, C. Seiler, K. Lindel, H. Schmitz-Winnenthal, S. Fritz, T. Herrmann, H. Goldschmidt, R. Krempien, U. Mansmann, J. Debus, V. Diehl and M.W. Büchler |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1788590171 | ||
| 003 | DE-627 | ||
| 005 | 20240516101614.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220204s2005 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-5-37 |2 doi | |
| 035 | |a (DE-627)1788590171 | ||
| 035 | |a (DE-599)KXP1788590171 | ||
| 035 | |a (OCoLC)1341441199 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Knaebel, Hanns-Peter |d 1968- |e VerfasserIn |0 (DE-588)1042050112 |0 (DE-627)768176484 |0 (DE-576)393674649 |4 aut | |
| 245 | 1 | 0 | |a Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI |b study protocol (ISRCTN62866759) |c H.P. Knaebel, A. Märten, J. Schmidt, K. Hoffmann, C. Seiler, K. Lindel, H. Schmitz-Winnenthal, S. Fritz, T. Herrmann, H. Goldschmidt, R. Krempien, U. Mansmann, J. Debus, V. Diehl and M.W. Büchler |
| 264 | 1 | |c 12 April 2005 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.02.2022 | ||
| 520 | |a After surgical intervention with curative intention in specialised centres the five-year survival of patients with carcinoma of the exocrine pancreas is only 15%. The ESPAC-1 trial showed an increased five-year survival of 21% achieved with adjuvant chemotherapy. Investigators from the Virginia Mason Clinic have reported a 5-year survival rate of 55% in a phase II trial evaluating adjuvant chemotherapy, immunotherapy and external-beam radiation | ||
| 650 | 4 | |a Autologous Tumor Cell | |
| 650 | 4 | |a Folinic Acid | |
| 650 | 4 | |a Interferon Alpha | |
| 650 | 4 | |a Intravenous Bolus Injection | |
| 650 | 4 | |a Resected Pancreatic Adenocarcinoma | |
| 700 | 1 | |a Märten, Angela |d 1968- |e VerfasserIn |0 (DE-588)122240103 |0 (DE-627)081822456 |0 (DE-576)293167931 |4 aut | |
| 700 | 1 | |a Schmidt, Jan |d 1961- |e VerfasserIn |0 (DE-588)1022937995 |0 (DE-627)717335852 |0 (DE-576)366198017 |4 aut | |
| 700 | 1 | |a Hoffmann, Katrin |d 1980- |e VerfasserIn |0 (DE-588)131774417 |0 (DE-627)513946950 |0 (DE-576)252913078 |4 aut | |
| 700 | 1 | |a Seiler, Christoph |d 1969- |e VerfasserIn |0 (DE-588)115783725 |0 (DE-627)077469828 |0 (DE-576)290075033 |4 aut | |
| 700 | 1 | |a Lindel, Katja |d 1972- |e VerfasserIn |0 (DE-588)121342689 |0 (DE-627)705399176 |0 (DE-576)292658044 |4 aut | |
| 700 | 1 | |a Schmitz-Winnenthal, Friedrich Hubertus |d 1970- |e VerfasserIn |0 (DE-588)123474892 |0 (DE-627)706312589 |0 (DE-576)293724377 |4 aut | |
| 700 | 1 | |a Fritz, Stefan |d 1976- |e VerfasserIn |0 (DE-588)128817526 |0 (DE-627)381568547 |0 (DE-576)181297868 |4 aut | |
| 700 | 1 | |a Herrmann, Thomas |e VerfasserIn |0 (DE-588)1235418685 |0 (DE-627)176045785X |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Krempien, Robert |d 1966- |e VerfasserIn |0 (DE-588)115540008 |0 (DE-627)691390169 |0 (DE-576)289939100 |4 aut | |
| 700 | 1 | |a Mansmann, Ulrich |e VerfasserIn |0 (DE-588)1047558459 |0 (DE-627)778551792 |0 (DE-576)401157695 |4 aut | |
| 700 | 1 | |a Debus, Jürgen |d 1964- |e VerfasserIn |0 (DE-588)1022671421 |0 (DE-627)717025780 |0 (DE-576)365774944 |4 aut | |
| 700 | 1 | |a Diehl, Volker |d 1938- |e VerfasserIn |0 (DE-588)120716437 |0 (DE-627)080847609 |0 (DE-576)160732212 |4 aut | |
| 700 | 1 | |a Büchler, Markus W. |d 1955- |e VerfasserIn |0 (DE-588)120893339 |0 (DE-627)080952526 |0 (DE-576)292434146 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 5(2005), Artikel-ID 37, Seite 1-8 |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI study protocol (ISRCTN62866759) |
| 773 | 1 | 8 | |g volume:5 |g year:2005 |g elocationid:37 |g pages:1-8 |g extent:8 |a Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI study protocol (ISRCTN62866759) |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2407-5-37 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220204 | ||
| 993 | |a Article | ||
| 994 | |a 2005 | ||
| 998 | |g 120893339 |a Büchler, Markus W. |m 120893339:Büchler, Markus W. |d 910000 |d 910200 |e 910000PB120893339 |e 910200PB120893339 |k 0/910000/ |k 1/910000/910200/ |p 15 |y j | ||
| 998 | |g 1022671421 |a Debus, Jürgen |m 1022671421:Debus, Jürgen |d 910000 |d 911400 |e 910000PD1022671421 |e 911400PD1022671421 |k 0/910000/ |k 1/910000/911400/ |p 13 | ||
| 998 | |g 115540008 |a Krempien, Robert |m 115540008:Krempien, Robert |d 910000 |d 911400 |e 910000PK115540008 |e 911400PK115540008 |k 0/910000/ |k 1/910000/911400/ |p 11 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 | ||
| 998 | |g 1235418685 |a Herrmann, Thomas |m 1235418685:Herrmann, Thomas |d 910000 |d 910100 |e 910000PH1235418685 |e 910100PH1235418685 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 128817526 |a Fritz, Stefan |m 128817526:Fritz, Stefan |d 910000 |d 910200 |e 910000PF128817526 |e 910200PF128817526 |k 0/910000/ |k 1/910000/910200/ |p 8 | ||
| 998 | |g 123474892 |a Schmitz-Winnenthal, Friedrich Hubertus |m 123474892:Schmitz-Winnenthal, Friedrich Hubertus |d 50000 |e 50000PS123474892 |k 0/50000/ |p 7 | ||
| 998 | |g 121342689 |a Lindel, Katja |m 121342689:Lindel, Katja |d 910000 |d 911400 |e 910000PL121342689 |e 911400PL121342689 |k 0/910000/ |k 1/910000/911400/ |p 6 | ||
| 998 | |g 115783725 |a Seiler, Christoph |m 115783725:Seiler, Christoph |d 910000 |d 910200 |e 910000PS115783725 |e 910200PS115783725 |k 0/910000/ |k 1/910000/910200/ |p 5 | ||
| 998 | |g 131774417 |a Hoffmann, Katrin |m 131774417:Hoffmann, Katrin |d 910000 |d 910200 |e 910000PH131774417 |e 910200PH131774417 |k 0/910000/ |k 1/910000/910200/ |p 4 | ||
| 998 | |g 1022937995 |a Schmidt, Jan |m 1022937995:Schmidt, Jan |d 910000 |d 910200 |e 910000PS1022937995 |e 910200PS1022937995 |k 0/910000/ |k 1/910000/910200/ |p 3 | ||
| 998 | |g 122240103 |a Märten, Angela |m 122240103:Märten, Angela |d 50000 |e 50000PM122240103 |k 0/50000/ |p 2 | ||
| 998 | |g 1042050112 |a Knaebel, Hanns-Peter |m 1042050112:Knaebel, Hanns-Peter |d 910000 |d 910200 |e 910000PK1042050112 |e 910200PK1042050112 |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1788590171 |e 4051372618 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["H.P. Knaebel, A. Märten, J. Schmidt, K. Hoffmann, C. Seiler, K. Lindel, H. Schmitz-Winnenthal, S. Fritz, T. Herrmann, H. Goldschmidt, R. Krempien, U. Mansmann, J. Debus, V. Diehl and M.W. Büchler"]},"language":["eng"],"id":{"eki":["1788590171"],"doi":["10.1186/1471-2407-5-37"]},"physDesc":[{"extent":"8 S."}],"person":[{"family":"Knaebel","given":"Hanns-Peter","display":"Knaebel, Hanns-Peter","role":"aut"},{"family":"Märten","role":"aut","given":"Angela","display":"Märten, Angela"},{"family":"Schmidt","role":"aut","given":"Jan","display":"Schmidt, Jan"},{"given":"Katrin","display":"Hoffmann, Katrin","role":"aut","family":"Hoffmann"},{"role":"aut","given":"Christoph","display":"Seiler, Christoph","family":"Seiler"},{"role":"aut","given":"Katja","display":"Lindel, Katja","family":"Lindel"},{"display":"Schmitz-Winnenthal, Friedrich Hubertus","given":"Friedrich Hubertus","role":"aut","family":"Schmitz-Winnenthal"},{"family":"Fritz","given":"Stefan","display":"Fritz, Stefan","role":"aut"},{"role":"aut","display":"Herrmann, Thomas","given":"Thomas","family":"Herrmann"},{"family":"Goldschmidt","given":"Hartmut","display":"Goldschmidt, Hartmut","role":"aut"},{"display":"Krempien, Robert","given":"Robert","role":"aut","family":"Krempien"},{"family":"Mansmann","given":"Ulrich","display":"Mansmann, Ulrich","role":"aut"},{"role":"aut","display":"Debus, Jürgen","given":"Jürgen","family":"Debus"},{"role":"aut","display":"Diehl, Volker","given":"Volker","family":"Diehl"},{"family":"Büchler","display":"Büchler, Markus W.","given":"Markus W.","role":"aut"}],"title":[{"subtitle":"study protocol (ISRCTN62866759)","title_sort":"Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI","title":"Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI"}],"note":["Gesehen am 04.02.2022"],"origin":[{"dateIssuedKey":"2005","dateIssuedDisp":"12 April 2005"}],"relHost":[{"origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedKey":"2001","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-"}],"note":["Gesehen am 22.05.20"],"pubHistory":["1.2001 -"],"recId":"326643710","language":["eng"],"id":{"issn":["1471-2407"],"zdb":["2041352-X"],"eki":["326643710"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"part":{"extent":"8","volume":"5","pages":"1-8","year":"2005","text":"5(2005), Artikel-ID 37, Seite 1-8"},"disp":"Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI study protocol (ISRCTN62866759)BMC cancer","physDesc":[{"extent":"Online-Ressource"}]}],"recId":"1788590171"} | ||
| SRT | |a KNAEBELHANPHASEIIITR1220 | ||